Will_Wong

LGND-A-B-C correction to wave {iv} nearing completion

做多
NASDAQ:LGND   Ligand Pharmaceuticals Incorporated
1
Entry point coming soon. With a recent earning report that surpassed estimates, LGND is expected to reach triple digit soon. A few analysts have upgraded LGND to a BUY with targets in the triple digits.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。